1. Home
  2. VVOS vs UTSI Comparison

VVOS vs UTSI Comparison

Compare VVOS & UTSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VVOS
  • UTSI
  • Stock Information
  • Founded
  • VVOS 2016
  • UTSI 1991
  • Country
  • VVOS United States
  • UTSI China
  • Employees
  • VVOS N/A
  • UTSI N/A
  • Industry
  • VVOS Medical Specialities
  • UTSI Telecommunications Equipment
  • Sector
  • VVOS Health Care
  • UTSI Telecommunications
  • Exchange
  • VVOS Nasdaq
  • UTSI Nasdaq
  • Market Cap
  • VVOS 27.3M
  • UTSI 24.9M
  • IPO Year
  • VVOS 2020
  • UTSI 2000
  • Fundamental
  • Price
  • VVOS $3.47
  • UTSI $2.20
  • Analyst Decision
  • VVOS Strong Buy
  • UTSI
  • Analyst Count
  • VVOS 2
  • UTSI 0
  • Target Price
  • VVOS $6.25
  • UTSI N/A
  • AVG Volume (30 Days)
  • VVOS 140.4K
  • UTSI 6.9K
  • Earning Date
  • VVOS 11-13-2025
  • UTSI 08-29-2025
  • Dividend Yield
  • VVOS N/A
  • UTSI N/A
  • EPS Growth
  • VVOS N/A
  • UTSI N/A
  • EPS
  • VVOS N/A
  • UTSI N/A
  • Revenue
  • VVOS $14,393,000.00
  • UTSI $9,793,000.00
  • Revenue This Year
  • VVOS $3.83
  • UTSI N/A
  • Revenue Next Year
  • VVOS $25.27
  • UTSI N/A
  • P/E Ratio
  • VVOS N/A
  • UTSI N/A
  • Revenue Growth
  • VVOS 2.65
  • UTSI N/A
  • 52 Week Low
  • VVOS $1.98
  • UTSI $1.84
  • 52 Week High
  • VVOS $7.95
  • UTSI $3.22
  • Technical
  • Relative Strength Index (RSI)
  • VVOS 35.25
  • UTSI 40.58
  • Support Level
  • VVOS $3.80
  • UTSI $2.30
  • Resistance Level
  • VVOS $4.63
  • UTSI $2.55
  • Average True Range (ATR)
  • VVOS 0.40
  • UTSI 0.14
  • MACD
  • VVOS -0.09
  • UTSI -0.02
  • Stochastic Oscillator
  • VVOS 0.60
  • UTSI 0.00

About VVOS Vivos Therapeutics Inc.

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp is providing telecommunication network products, solutions and services. It focus on delivering carrier-class packet optical, network synchronization and broadband access (both wireless and fixed line) products and solutions, coupled with Software Defined Networking (SDN) platform, optimized for mobile backhaul, metro aggregation, broadband access and value added services. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. Key revenue is generated from Equipment segment.

Share on Social Networks: